BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image
Active
Mainboard

Sai Life Sciences Ltd

Sai Life Sciences Ltd IPO Details

Listing Date

18 Dec 2024

Bid Price

₹522 - ₹549

Lot Size

27 Shares

Minimum Investment

₹14,823 / Lot

Issue Size

₹3042.62 Crores

Schedule

    Here are the important dates you need to know in order to participate in this IPO

tick

Bidding starts

11th Dec

tick

Bidding ends

13th Dec

tick

Allotment of shares

16th Dec

tick

Initiation of refund

17th Dec

tick

Credit of shares to Demat account

17th Dec

tick

Listing date

18th Dec

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 41.46% 35.24%
Public Group 58.54% 64.76%

Sai Life Sciences Ltd IPO Reservation

QIB Shares Offered 1,10,84,225 (20%)
NII (HNI) Shares Offered 83,13,168 (15%)
Retail Shares Offered 1,93,97,392 (35%)
Anchor Investor Shares Offered 1,66,26,337 (30%)
Total Shares Offered 5,54,21,124
Total Shares With Anchor Investor 5,54,21,124

Sai Life Sciences Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 27 ₹14,823
Retail (Max) 13 351 ₹1,92,699
S HNI (Min) 14 378 ₹2,07,522
S HNI (Max) 67 1,809 ₹9,93,141
B HNI (MIN) 68 1,836 ₹10,07,964

Sai Life Sciences Ltd IPO Anchor Investor Details

Bid Date December 10, 2024
Shares Offered 1,66,26,336
Anchor Investment Details 912.7858464

Sai Life Sciences Ltd IPO registrar

KFin Techologies Ltd
Phone Number +91 40 6716 2222
Email Id einward.ris@kfintech.com
Website www.kfintech.com

Sai Life Sciences Ltd IPO Lead Manager

1. Kotak Mahindra Capital Company Ltd

2. IIFL Securities Ltd

3. Jefferies India Pvt Ltd

4. Morgan Stanley India Company Pvt Ltd

Sai Life Sciences Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹2,128.35 cr ₹975.14 cr ₹888.09 cr
Reserves and Surplus ₹2,107.51 cr ₹957.09 cr ₹870.08 cr
Total Borrowing ₹128.64 cr ₹710.16 cr ₹699.23 cr

Sai Life Sciences Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed
Qualified Institutional Buyers (QIBs) 1,06,71,763 33,01,25,058 30.9344
Non Institutional Investors (NIIs) 84,47,426 4,15,22,058 4.9154
NII(Bid amount of more than Ten Lakh Rupees) 56,31,618 3,38,13,693 6.0043
NII(Bid amount of more than 2 Lakh < 10 Rupees) 28,15,808 77,08,365 2.7375
Retail Individual Investors (RIIs) 1,97,10,659 2,69,12,412 1.3654
Total 3,88,29,848 39,85,59,528 10.26

Strength of Sai Life Sciences Ltd

  • One of the largest integrated Indian CRDMOs in terms of revenue from operations for the Financial Year 2024, acting as a one-stop platform for discovery, development and manufacturing.
  • CDMO platform with a diverse mix of commercial and under-development molecules.
  • Fast-growing, integrated Discovery capabilities with focus on biology, chemistry and DMPK services.
  • Long-standing relationship with a diverse base of existing and new customers.
  • Modern R&D infrastructure with a differentiated delivery model and strong regulatory track-record.
  • Experienced management team and Board supported by a qualified scientific talent pool.
  • Strategic business investments with improving profitability metrics.

Risks Involved

  • Its financial performance depends on the company's ability to secure business from biotechnology and pharmaceutical customers and consequently its may be subject to risks, uncertainties and trends that affect the company customers in these industries over which the company has no control.
  • Its business may be adversely affected by a failures to develop or manufacture commercially viable drugs, including for reasons that are not within the company control.
  • The company may not be able to continue to serve its customers if the company fails to meet their standards in audits and inspections and this could significantly harm its reputation and result in the termination of ongoing projects by its customers.
  • The company depends on its research and development activities generally for the company future growth and its inability to achieve the desired outcomes in the company research and development activities may result in customers opting to discontinue their partnerships with it.
  • The company is subject to extensive government regulation, and if the company fails to obtain, maintain or renew its statutory and regulatory licenses, permits and approvals required to operate the company's business, results of operations and cash flows may be adversely affected.
  • Manufacturing interruptions or delays could affect its ability to meet customer demand and lead to higher costs.
  • The company generated a revenue of Rs.6,542.20 million and Rs.14,386.02 million for the six months period ended September 30, 2024 and year ended March 31, 2024 respectively from customers outside India, amounting to 97.40% and 97.95% of total revenue from contract research, development and manufacturing activities, respectively. Furthermore, The company is subject to risks associated with conducting business internationally, and any operational delays and/or additional financial burdens may affect its business and results of operations.
  • Its largest customer contributed 8.00% and 9.55% of the total revenue from operation for the six months period ended September 30, 2024 and the year ended March 31, 2024 respectively. The potential loss of major customers or any of its large contracts could materially and adversely affect the company's business, financial condition and results of operations.
  • The company conduct animal testing, which can result in adverse publicity liability and other issues, including potential disruption to its facilities as a result of protests against animal testing.
  • Its subsidiary, Sai Life Sciences Inc. has incurred losses of Rs.45.66 million, Rs.150.60 million, Rs.125.97 million and Rs.93.10 million for the six months period ended September 30, 2024 and the Financial Years ended March 31, 2024, March 31, 2023 and March 31, 2022, respectively, and it may also incur losses in the future, which may adversely impact its business and the value of the Equity Shares.
stock

Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
Global Ocean Logistics India Limited IPO
Bidding Period
17th Dec 2025 - 12th Dec 2025
Price Range
₹74.0 - 78.0
IPO Size
₹30,41,00,000
Marc Technocrats Limited IPO
Bidding Period
17th Dec 2025 - 12th Dec 2025
Price Range
₹88.0 - 93.0
IPO Size
₹42,59,00,000
Aarvee Engineering Consultants Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aggcon Equipments International Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alcobrew Distilleries India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allied Engineering Works Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amagi Media Labs Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Amir Chand Jagadish Kumar Exports Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AOne Steels India Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
APPL Containers Limited IPO
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
NEPHROCARE HEALTH SERVICES LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹438.0 - 460.0
IPO Size
₹8,71,05,00,000
PARK MEDI WORLD LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹154.0 - 162.0
IPO Size
₹9,20,00,00,000
SHIPWAVES ONLINE LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹12.0 - 12.0
IPO Size
₹56,35,00,000
UNISEM AGRITECH LIMITED IPO
Bidding Period
10th Dec 2025 - 12th Dec 2025
Price Range
₹63.0 - 65.0
IPO Size
₹21,45,00,000
WAKEFIT INNOVATIONS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹185.0 - 195.0
IPO Size
₹12,88,89,00,000
RIDDHI DISPLAY EQUIPMENTS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹95.0 - 100.0
IPO Size
₹24,68,00,000
PRODOCS SOLUTIONS LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹131.0 - 138.0
IPO Size
₹27,60,00,000
K V TOYS INDIA LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹227.0 - 239.0
IPO Size
₹40,15,00,000
CORONA REMEDIES LIMITED IPO
Bidding Period
8th Dec 2025 - 12th Dec 2025
Price Range
₹1008.0 - 1062.0
IPO Size
₹6,55,37,00,000
ENCOMPASS DESIGN INDIA LIMITED IPO
Bidding Period
5th Dec 2025 - 12th Dec 2025
Price Range
₹101.0 - 107.0
IPO Size
₹40,21,00,000
FLYWINGS SIMULATOR TRAINING CENTRE LIMITED IPO
Bidding Period
5th Dec 2025 - 12th Dec 2025
Price Range
₹181.0 - 191.0
IPO Size
₹57,05,00,000
METHODHUB SOFTWARE LIMITED IPO
Bidding Period
5th Dec 2025 - 12th Dec 2025
Price Range
₹190.0 - 194.0
IPO Size
₹1,03,02,00,000
LUXURY TIME LIMITED IPO
Bidding Period
4th Dec 2025 - 12th Dec 2025
Price Range
₹78.0 - 82.0
IPO Size
₹18,74,00,000
WESTERN OVERSEAS STUDY ABROAD LIMITED IPO
Bidding Period
4th Dec 2025 - 12th Dec 2025
Price Range
₹56.0 - 56.0
IPO Size
₹10,07,00,000
VIDYA WIRES LIMITED IPO
Bidding Period
3rd Dec 2025 - 12th Dec 2025
Price Range
₹48.0 - 52.0
IPO Size
₹3,00,01,00,000
MEESHO LIMITED IPO
Bidding Period
3rd Dec 2025 - 12th Dec 2025
Price Range
₹105.0 - 111.0
IPO Size
₹54,21,20,00,000
SHRI KANHA STAINLESS LIMITED IPO
Bidding Period
3rd Dec 2025 - 12th Dec 2025
Price Range
₹90.0 - 90.0
IPO Size
₹46,28,00,000
AEQUS LIMITED IPO
Bidding Period
3rd Dec 2025 - 12th Dec 2025
Price Range
₹118.0 - 124.0
IPO Size
₹9,21,81,00,000
HELLOJI HOLIDAYS LIMITED IPO
Bidding Period
2nd Dec 2025 - 12th Dec 2025
Price Range
₹110.0 - 118.0
IPO Size
₹10,96,00,000
NEOCHEM BIO SOLUTIONS LIMITED IPO
Bidding Period
2nd Dec 2025 - 12th Dec 2025
Price Range
₹93.0 - 98.0
IPO Size
₹44,97,00,000
  • All
  • MainBoard
  • SME
ENCOMPASS DESIGN INDIA LIMITED IPO
Issue Prize
107.00
Listing Day Close
193.15(80.37%)
FLYWINGS SIMULATOR TRAINING CENTRE LIMITED IPO
Issue Prize
191.00
Listing Day Close
204.75(7.33%)
METHODHUB SOFTWARE LIMITED IPO
Issue Prize
194.00
Listing Day Close
162.90(-15.98%)
LUXURY TIME LIMITED IPO
Issue Prize
82.00
Listing Day Close
163.59(100.00%)
WESTERN OVERSEAS STUDY ABROAD LIMITED IPO
Issue Prize
56.00
Listing Day Close
52.16(-7.14%)
VIDYA WIRES LIMITED IPO
Issue Prize
52.00
Listing Day Close
53.14(1.92%)
MEESHO LIMITED IPO
Issue Prize
111.00
Listing Day Close
170.20(53.15%)
SHRI KANHA STAINLESS LIMITED IPO
Issue Prize
90.00
Listing Day Close
83.60(-6.67%)
AEQUS LIMITED IPO
Issue Prize
124.00
Listing Day Close
151.50(22.58%)
HELLOJI HOLIDAYS LIMITED IPO
Issue Prize
118.00
Listing Day Close
123.90(5.08%)
NEOCHEM BIO SOLUTIONS LIMITED IPO
Issue Prize
98.00
Listing Day Close
111.80(14.29%)
INVICTA DIAGNOSTIC LIMITED IPO
Issue Prize
85.00
Listing Day Close
96.70(14.12%)
RAVELCARE LIMITED IPO
Issue Prize
130.00
Listing Day Close
190.95(46.92%)
ASTRON MULTIGRAIN LIMITED IPO
Issue Prize
63.00
Listing Day Close
47.88(-23.81%)
CLEAR SECURED SERVICES LIMITED IPO
Issue Prize
132.00
Listing Day Close
113.05(-14.39%)
SPEB ADHESIVES LIMITED IPO
Issue Prize
56.00
Listing Day Close
57.00(1.79%)
EXATO TECHNOLOGIES LIMITED IPO
Issue Prize
140.00
Listing Day Close
279.30(99.29%)
PURPLE WAVE INFOCOM LIMITED IPO
Issue Prize
126.00
Listing Day Close
130.50(3.97%)
LOGICIEL SOLUTIONS LIMITED IPO
Issue Prize
193.00
Listing Day Close
146.70(-23.83%)
MOTHER NUTRI FOODS LIMITED IPO
Issue Prize
117.00
Listing Day Close
124.30(5.98%)

Frequently Asked Questions

What is Sai Life Sciences Ltd IPO?

Answer Field

Sai Life Sciences Ltd IPO is a Mainboard IPO of 5,54,21,124 equity shares of a face value of ₹1 aggregating up to ₹3042.62 Crores. The issue is priced at ₹522 to ₹549 per share. The minimum order quantity is 27 Shares. The IPO opens on December 11, 2024, and closes on December 13, 2024. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

When Sai Life Sciences Ltd IPO will open?

Answer Field

The Sai Life Sciences Ltd IPO opens on December 11, 2024 and closes on December 13, 2024.

What is the lot size of Sai Life Sciences Ltd?

Answer Field

Sai Life Sciences Ltd lot size is 27 shares, and the minimum amount required is ₹14,823.

How to apply for Sai Life Sciences Ltd IPO?

Answer Field

You can apply in Sai Life Sciences Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Sai Life Sciences Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Sai Life Sciences Ltd IPO will be done on December 16, 2024, and the allotted shares will be credited to your demat account by December 17, 2024.

When is Sai Life Sciences Ltd IPO listing date?

Answer Field

The Sai Life Sciences Ltd listing date is December 18, 2024.

Who is the registrar of Sai Life Sciences Ltd IPO?

Answer Field

The registrar of Sai Life Sciences Ltd IPO is KFin Techologies Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Kotak Mahindra Capital Company Ltd,IIFL Securities Ltd,Jefferies India Pvt Ltd,Morgan Stanley India Company Pvt Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Sai Life Sciences Ltd IPO?

Answer Field

The fresh issue size is ₹950 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Sai Life Sciences Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 27 shares and ₹14,823 amount.

How can I approve the UPI mandate request for Sai Life Sciences Ltd IPO?

Answer Field

To apply for Sai Life Sciences Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Sai Life Sciences Ltd?

Answer Field

The price of each Sai Life Sciences Ltd share will be ranging in between ₹522 to ₹549 per share.

What is the cut-off time for the UPI mandate for Sai Life Sciences Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, December 13, 2024.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|